PreTeL, Inc.
PrivateLast Round
Seed
Jun 26, 2026
Total Funding Raised
$3.18M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
PreTeL, Inc. operates in Healthcare & Life Sciences and is based in Chattanooga, Tennessee. Its latest recorded funding round was a Seed round in June 2026.
PreTeL, Inc. is a Femtech company that develops uterine electromyography monitoring sensors and intelligent analysis platforms to improve maternal and neonatal health outcomes.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Sensors, Clinical Trials, Telemedicine, Medical AI
Business Model
B2B
Customer Profile
Hardware + Subscription, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PreTeL, Inc. Comparables
Compare PreTeL, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Bloomlife | 80% | |
| Nemo Healthcare BV | 80% | |
| Sibel Health | 79% |
For institutional investors. Book with your work email.
PreTeL, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jun 26, 2026 | ||||
| Grant | Sep 19, 2023 | ||||
| Grant | Aug 29, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
PreTeL, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| Tennessee Technology Development Corporation | Grant |
| University of Tennessee Research Foundation | Seed |
| Charleston Angel Partners | Seed |
| Solas BioVentures | Seed |
| Tech Square Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 26, 2026
$1.5M round with participation from Tech Square Ventures and Solas BioVentures.
- Apr 15, 2025
Grew 17% QoQ, from 23 to 27 employees.
For institutional investors. Book with your work email.
PreTeL, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about PreTeL, Inc.'s valuation, stock price, and market status.
Is PreTeL, Inc. a public or private company?
PreTeL, Inc. is a private company.
What is the current stock price of PreTeL, Inc.?
PreTeL, Inc. is a private company, so its shares have no public market price. Caplight tracks PreTeL, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is PreTeL, Inc. worth (valuation)?
Valuation information for PreTeL, Inc. is not publicly available.
Can I buy PreTeL, Inc. stock?
PreTeL, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was PreTeL, Inc.'s last funding round?
PreTeL, Inc.'s most recent funding round was Seed on June 26, 2026.
Who are the main investors in PreTeL, Inc.?
Key investors in PreTeL, Inc. include NIH RADx, Tennessee Technology Development Corporation, University of Tennessee Research Foundation, Charleston Angel Partners, Solas BioVentures.
Will PreTeL, Inc. IPO soon?
No public IPO plans have been announced for PreTeL, Inc..
How can I track PreTeL, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in PreTeL, Inc.'s shares on secondary markets.